8-K
filed May 14, 2024, 7:59 PM ET
ticker KRMD
CIK 0000704440
other
confidence high
sentiment neutral
materiality 0.15
Koru Medical Systems reports 2024 annual meeting results; all proposals passed
KORU Medical Systems, Inc.
- Elected all 7 director nominees: Fletcher, Cascella, French, Manko, Matin, Tharby, Wholihan.
- Advisory compensation vote approved: 26.4M for, 0.5M against, 0.2M abstain.
- Ratified McGrail Merkel Quinn as independent auditor for 2024 (38.3M for, 11.5K against).
- Approved 2024 Omnibus Equity Incentive Plan (26.1M for, 0.8M against, 0.2M abstain).
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.98
KORU Medical Systems, Inc. shareholders approved Election of Directors at the 2024-05-09 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2024-05-09
Exact text from the filing
Proposal 1: Election of Directors The nominees for director set forth under “Nominees” below were elected to the Company’s board of directors. Number of Shares Nominees For Withheld Broker Non-Vote R. John Fletcher 25,929,278 1,195,646 11,214,184
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.98
KORU Medical Systems, Inc. shareholders approved Approval of the 2024 Omnibus Equity Incentive Plan at the 2024-05-09 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2024-05-09
Exact text from the filing
Proposal 4: Approval of the 2024 Omnibus Equity Incentive Plan. The Company’s shareholders approved the adoption of the Company’s 2024 Omnibus Equity Incentive Plan. For Against Abstain Number of Shares 26,146,895 814,966 163,063
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.98
KORU Medical Systems, Inc. shareholders approved Approval, on an advisory basis, of the compensation of the Company’s executive officers at the 2024-05-09 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2024-05-09
Exact text from the filing
Proposal 2: Approval, on an advisory basis, of the compensation of the Company’s executive officers. The Company’s shareholders, on an advisory basis, approved the compensation of the company’s executive officers. For Against Abstain Broker Non-Vote Number of Shares 26,409,104 541,923 173,897 11,214,184
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.98
KORU Medical Systems, Inc. shareholders approved Ratification of the appointment of independent registered accountants for the 2024 fiscal year at the 2024-05-09 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2024-05-09
Exact text from the filing
Proposal 3: Ratification of the appointment of independent registered accountants for the 2024 fiscal year. The Company’s shareholders ratified the appointment of McGrail Merkel Quinn & Associates, P.C. as the company’s independent registered public accountants for the 2024 fiscal year. For Against Abstain Number of Shares 38,261,457 11,517 66,134
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.